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Abstract:
In the multiple therapies which may synergize HBOT the use of

Laser (photodynamic) therapy is not well known in North
America.
In this session Dr. Anderson will outline his use of HBOT-Laser
and IV Therapies to enhance mitochondrial function and
healing.
Mechanisms of action and common complementary
modalities will be discussed.
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Photodynamic Therapies
Laser
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PDT - Laser
• Stem cell activation
• Immunologic stimulation
• Mitochondrial support
• Direct cancer therapy
• And: Synergy with HBOT
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References / Links for those papers
• Stem Cell Support Part-1
https://www.academia.edu/36317398/Stem_Cell_Support_Part1_Integrative_Pain_Management
• Stem Cell Support Part-2
https://www.academia.edu/36317439/Stem_Cell_Support_Part2_Integrative_Pain_Management
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Given the MOA of PDT it appears that HBOT
and PDT are synergistic:
Any Data?
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PMID: 10691271 (2000) +
BACKGROUND AND STUDY AIMS: Experimental studies have shown that the cytotoxicity of
porphyrins and related substances is mediated mainly by singlet oxygen and that hypoxic cells are
less affected by porphyrins and light. In a clinical pilot study we assessed the use of photodynamic
therapy (PDT) under hyperbaric oxygen (HBO), compared with PDT under normobaric conditions, in
patients with advanced esophageal carcinoma.
PATIENTS AND METHODS: …Of the patients, 14 (12 with stage III cancers, and two with stage IV
cancers) were treated by PDT alone, and 17 patients (15 with stage III cancers, and two with stage
IV cancers) received PDT under HBO at a level of 2 absolute atmospheric pressures (ATA).
Transcutaneous PO2 levels of 500-750 mm Hg under HBO, compared with transcutaneous PO2
levels of 60-75 mm Hg under normobaric conditions, were measured.
RESULTS: …The 12-month survival rate was 28.6% for the PDT group and 41.2% for the PDT/HBO
group. Logrank test showed a difference in survival in favor of the PDT/HBO group (P = 0.059). No
major treatment-related complication occurred, and the 30-day mortality rate was 0%.
CONCLUSIONS: Combined PDT/HBO represents a new approach in the treatment of esophageal
cancer which, in this pilot study, appears to have enhanced the efficiency of PDT.
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https://doi.org/10.1002/(SICI)1096-9101(2000)26:3<308::AID-LSM9>3.0.CO;2-B

(2000) +
Background and Objective: The photochemical reaction of photodynamic therapy
(PDT) depends on the presence of molecular oxygen. Because of anoxic regions in
tumor tissue and vascular shutdown during PDT, the efficiency is limited.
Therefore, the use of hyperbaric oxygen, which increases the oxygen in tumor
tissue, as well as the amount of singlet oxygen, may enhance the efficiency of PDT.
Study Design/Materials and Methods: Twenty‐three patients were treated by PDT
alone and 29 patients received PDT under hyperbaric oxygen at a level of two
absolute atmospheric pressures.
Results: …The mean overall survival was 11.3 months. The mean survival time for
the PDT group was 8.7 months and for the PDT/HBO group 13.8 months (P =
0.021).
Conclusion: According to this pilot study, combined PDT/HBO represents a new
approach in the treatment of esophageal and cardia cancer, which appears to have
enhanced the efficiency of PDT.
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https://doi.org/10.1002/lsm.1067
(2001) +
Background and Objective: Photodynamic tumor therapy (PDT) is based upon a
photochemical reaction that is limited by the availability of molecular oxygen in the target
tissue. The use of hyperbaric oxygenation (HBO) increases the amount of oxygen available
for the process may thereby enhance the efficacy of PDT. We investigated the acute effects
on tumor stenosis after combined PDT/HBO.
Patients and Methods: Thirty patients (22 males, 8 females, mean age: 68.8 years; range:
44–78 years) with inoperable non‐small cell bronchogenic carcinoma and endobronchial
stenosis were studied prospectively.
Results: …A significant reduction of tumor stenosis (P < 0.05) and an improvement of the
Karnofsky performance status (P < 0.05) were documented 1 and 4 weeks after
PDT/HBO. No therapy related complications were observed.
Conclusions: Although the small number of patients does not allow to draw definitive
conclusions to be drawn, the results suggests that combined PDT/HBO represents a new,
safe, and technically feasible approach. It enables efficient and rapid reduction of the
endoluminal tumor load and helps conditioning the patient for further treatment
procedures.
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https://doi.org/10.1016/S1572-1000(04)00009-2

(2004) +
Introduction: … The aim of this study was to evaluate the additional effect of intraoperative
photodynamic therapy (PDT) under hyperbaric oxygenation (HBO) if compared to
decortication alone.
Patients and methods: From January 1993 to August 2003, decortication was done in 34
patients (28 males, 6 females; mean age: 65 years) suffering from advanced malignant
pleural mesothelioma. Twenty-two patients received additional intraoperative PDT under
HBO.
Results: At 6-month follow-up the Karnofsky performance status showed no significant
difference (P≥0.05) between both groups. CT scans documented focal regrowth of the
tumour after 6 months in 10/12 cases of the non-PDT group. However, in the PDT group
tumour regrowth was detected in only 9/22 cases at 6-month follow-up.
Conclusion: Although the study includes only a small number of patients, it indicates that
additional PDT/HBO represents a safe and technically feasible approach in the palliative
setting of advanced malignant mesothelioma of the pleura.
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Other Data?
• (2016) + A. Neves, A. Abrantes, A. Pires, R. Teixo, M.F. Botelho.
Hyperbaric oxygen therapy combined with photodynamic therapy as
a new therapeutic approach against retinoblastoma. DOI:
https://doi.org/10.1016/S0959-8049(16)61507-1
• (2016) Excellent review with extensive immunology data on PDT:
Photodynamic Therapy of Non–Small Cell Lung Cancer. Narrative
Review and Future Directions. https://doi.org/10.1513/Annals
ATS.201509-650FR.PMID26646726
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Synergizing Upconversion Nanophotosensitizers with Hyperbaric Oxygen to Remodel the Extracellular
Matrix for Enhanced Photodynamic Cancer Therapy. ACS Appl. Mater. Interfaces 10, 27, 22985-22996

(2018) +
“With HBO, photodynamic process can generate abundant ROS in the
intrinsically hypoxic tumor. It is revealed for the first time that HBOassisted PDT decomposes collagen in the extracellular matrix of tumor
and thus facilitates the diffusion of oxygen and penetration of UNPSs
into the deeper area of tumor. Such a synergic effect eventually results
in a significantly enhanced therapeutic efficacy at a low laser power
density as compared with that using UNPSs alone. In view of its good
biosafety, the HBO-assisted and UNPSs-mediated PDT provides new
possibilities for treatment of solid tumors.”
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Photosensitizers:
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Poly-MVA
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Poly-MVA
aka. Lipoic Acid Mineral Complex (LAMC):
Known as the proprietary formula “Poly MVA” in North
America, LAMC has shown to be helpful in cell repair,
mitochondrial repair and radioprotection [18-21].

The author has found that low IV doses (5-15 mL) combined
with low oral doses (5-10 mL BID) improve energy via

mitochondrial support.
(c) PS Anderson www.ConsultDrA.com 2018

26

Poly-MVA Reference
LAMC (PolyMVA) – Anderson
https://www.academia.edu/20316600/Lipoic_Acid_Mineral_Complex_
PolyMVA_Monograph
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Poly-MVA as a support
AND
Photosensitizer
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Poly-MVA Full Strength
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Poly-MVA 50% Dilution
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Poly-Plus (with retinoid)
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Silver Nanoparticles
(we use 23 ppm Argentyn)
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Thiamine (B-1)

DOI: 10.5897/AJPP2016.4542
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Riboflavin (B-2)

doi:10.1167/iovs.12-9537
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Niacin (B-3)

https://www.propharmagroup.com/blog/impact-wavelength-accuracy-and-precision-spectrophotometric-measurements/
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NAD-NADH from Nicotinamide (B-3)

https://socratic.org/questions/how-does-a-spectrophotometer-work
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Pantothenic Acid (B-5)

http://pubs.rsc.org/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/Articleimage/2015/RA/c5ra14720d/c5ra147
20d-f7_hi-res.gif
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Vitamin C

https://www.researchgate.net/profile/Aitziber_Cortajarena/publication/308698287/figure/fig2/AS:414508720902145@1475837988353/Fluorescenceemission-spectra-of-C3-Cys-stabilized-AuNCs-under-different-reaction.png
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B-12

http://www.pnas.org/content/pnas/103/15/5694/F3.large.jpg
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B-6; Folate; B-12

https://www.researchgate.net/publication/236958986/figure/fig2/AS:202804317691911@1425363725533/UV-spectra-of-homocysteine-1-mg-mlvitamin-B6-1-mg-ml-folic-acid-1-mg-ml-and.png
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Summary:
• PDT Laser is an incredibly potent therapy
• PDT – Laser has many potential applications in
chronic, acute and cancerous states.
• PDT + HBOT has been shown to be synergistic
• Multiple photosensitizers beyond the “known agents”
are available and potentially synergistic.
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NEW!
Integrative
Oncology
Book
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Next:
• AAMP Portland: Chronic Infectious Illness and Advanced Integrative
Medicine. September 28 - 30, 2018
www.aampportland.com
• Dr. A Web:
www.ConsultDrA.com
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Thanks
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